Asset sale Pending Sponsor buyer Sponsor exit
EQT X acquisition of Corza Biosurgery
Announced 7 Jul 2026
Advisers
Corza Biosurgery
Target
- Financial adviser
- Legal adviser
EQT X
Acquirer
- Financial adviser
- Legal adviser
- Target
- Corza Biosurgery
- Acquirer
- EQT X
- Sponsor
- GTCR
- Seller
- Corza Medical
- Target based in
- Austria (unverified)
- Buyer based in
- Sweden
- Seller based in
- United States (unverified)
- Sector
- Medtech
In the league tables
Similar deals
- Everis Medical and Hemostasis merger Nov 2026 · Medtech
- Rockwell Medical acquisition of Vantive hemodialysis assets and associated operations Nov 2026 · Medtech
- Acquisition of MEI Oct 2026 · Medtech
- Blackbird stake in Heidi Oct 2026 · Medtech
- Genetic Signatures and Microba Life Sciences merger Sep 2026 · Medtech
Sources
- Jul 2026 Kirkland Advises GTCR-Backed Corza Medical on Divestiture of Biosurgery Business Unit to EQT kirkland.com
- Jul 2026 Latham Watkins Advises EQT in Acquisition of TachoSil Biosurgery Business from Corza Medical lw.com
- 7 Jul 2026 Press release (PR Newswire), GTCR Announces Divestiture of Corza Medical's Biosurgery Business Unit to EQT prnewswire.com
- 7 Jul 2026 Press release (PR Newswire), EQT to acquire the TachoSil® biosurgery business from Corza Medical prnewswire.com



